Product Program year 2025 Source: CMS Open Payments

Andembry

Biological Hematology

NDC 63833-925-01

Open in the dashboard

General payments

$1,522,037

7,127 payments

Research payments

$480,741

256 payments

Through program year 2025, $1,522,037 in general payments and $480,741 in research payments were reported against Andembry (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $1,522,037 7,127
2025 Research $480,741 256

Breakdown

Who paid General payments · program year 2025
  1. CSL Behring $1,522,037 7,127 payments
Top recipients General payments · program year 2025
  1. Cristine Radojicic Allergy & Immunology · Durham, NC $118,630 8% · 90 payments
  2. William Lumry Dallas, TX $96,909 6% · 73 payments
  3. Mark Glaum Allergy & Immunology · Tampa, FL $81,661 5% · 75 payments
  4. Raffi Tachdjian Allergy & Immunology · Santa Monica, CA $77,143 5% · 65 payments
  5. Huamin Li Allergy · Wheaton, MD $64,800 4% · 58 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Allergy & Immunology $962,501 68% · 870 practitioners
  2. Allergy Allergy & Immunology $215,287 15% · 158 practitioners
  3. Allergy & Immunology Internal Medicine $121,208 9% · 80 practitioners
  4. Pediatric Allergy/Immunology Pediatrics $31,755 2% · 39 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $25,759 2% · 283 practitioners

The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $281,421 18% · 172 recipients
  2. Texas $158,665 10% · 160 recipients
  3. North Carolina $150,186 10% · 86 recipients
  4. Florida $130,022 9% · 226 recipients
  5. Pennsylvania $115,205 8% · 131 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

7,127 general · 256 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record